ProMIS to Report Third Quarter Results

The clinical-stage biotech will release its Q3 2026 financials and host an investor call on November 12, 2026.

Updated on Nov. 3, 2026 in Corporate Finance

ProMIS to Report Third Quarter Results

ProMIS Neurosciences Inc. will report its third quarter 2026 financial results on November 12, 2026, covering the period ended September 30, 2026. The company will also provide corporate updates alongside the results.

Why it matters

The release offers investors a scheduled look at the financial position and corporate progress of the clinical-stage biotechnology company listed on Nasdaq under the symbol PMN. The company has also published an investor Q&A on the scientific rationale for its PMN310 program.

The investor conference call and webcast begin at 4:30 p.m. Eastern Time on November 12, 2026, with a replay available in the Investors section of the ProMIS website afterward. The actual financial figures have not yet been disclosed and will be released with the results.

The players

ProMIS Neurosciences Inc.

ProMIS Neurosciences is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, with a secondary office in Toronto, Ontario, and is listed on Nasdaq under the symbol PMN.

The details

ProMIS Neurosciences will report third quarter 2026 financial results on November 12, 2026, and host an investor conference call and webcast the same day at 4:30 p.m. ET. A replay will be posted in the Investors section of the company's website after the call ends.

Timeline

  1. November 3, 2026: ProMIS announces the date of its third quarter results.

  2. November 12, 2026: Third quarter results are released and the investor call begins at 4:30 p.m. ET.

  3. September 30, 2026: The third quarter reporting period ends.

Market Dynamics

The scheduled third quarter report arrives as ProMIS continues development of its PMN310 program, which the company has explained in a published investor Q&A on its scientific rationale. Earnings releases from clinical-stage biotechs often pair financial results with pipeline updates, as ProMIS plans to do here.

Shareholders and prospective investors in PMN can review the company's third quarter financial position and corporate updates on November 12, 2026. The replay on the Investors section of the ProMIS website allows those who cannot attend the live call to follow the results.

The takeaway

Investors tracking ProMIS should mark November 12, 2026 on their calendars to review the third quarter results and corporate updates. The live call at 4:30 p.m. ET and the later replay give shareholders two ways to follow the company's report.

What happens next

ProMIS will host its third quarter 2026 investor conference call and webcast on November 12, 2026, at 4:30 p.m. ET, with a replay available afterward on the company's website.

Further reading

For more on how companies like this report results to shareholders, see Corporate Finance.